MD Anderson receives $22.2 million in CPRIT grants

Funding underscores institution's excellence, impact

BY Ron Gilmore

©ISTOCK.COM/BLACKJACK3D

MD Anderson received more than $22 million in research grants from the Cancer Prevention and Research Institute of Texas (CPRIT) in November. More than 35% of funds awarded for Individual Investigator Awards went to MD Anderson faculty, as well as nearly 40% of funds awarded for recruitment, reflecting the excellence and impact of the institution's world-class cancer researchers and star recruitment candidates.

Across Texas institutions, CPRIT awarded a total of $112 million in 73 new grants. MD Anderson CPRIT awards included $14.8 million for research, $6 million for recruitment funding and $1.4 million for evidence-based cancer prevention services. Consistent with MD Anderson's broad research program, these CPRIT awards will fund exciting studies in cancers of the liver, skin, pancreas and ovary, as well as lymphoma, leukemia and other cancers.

Programs made possible with CPRIT funding have reached every corner of the state, brought more than 100 distinguished researchers to Texas, advanced scientific and clinical knowledge, and provided more than 2.6 million life-saving education, training, prevention and early detection services to Texans.

More Stories From Promise

Global ambassadors with a collective goal: Making Cancer History®

The MD Anderson Cancer Center Board of Visitors plays a significant role in advancing the institution as the world's premier cancer center.

My Moon Shot

Tom Rushing, of Houston, is a pancreatic cancer survivor of eight years. After his initial diagnosis, he sought a second opinion at MD Anderson and was placed in the care of Robert Wolff, M.D., chair ad interim, General Oncology; Sheikh Zayed Distinguished University Chair in Medical Oncology; and a co-leader of the Pancreatic Cancer Moon Shot. A senior consultant with Merrill Lynch, Rushing has been a member of the MD Anderson Cancer Center Board of Visitors since 2011, serving on the board's Development Committee.

About the Pancreatic Cancer Moon Shot

Learn more about the Pancreatic Cancer Moon Shot

The Moon Shots Program Overview

MD Anderson's Moon Shots Program is an unprecedented, comprehensive assault to significantly reduce cancer deaths and transform cancer care.

A lasting legacy

New York conservationist gives $30 million to cancer research

A Conversation With a Living Legend®

A signature event, steeped in tradition

iPromise

Businesswoman, educator, philanthropist and sports enthusiast Nita Ambani, of Mumbai, India, joined the MD Anderson Cancer Center Board of Visitors in 2014. She is founder and chairperson of the Reliance Foundation, established in 2010 to provide impetus to various philanthropic initiatives of Reliance Industries Limited. The efforts of the group have touched the lives of more than 4 million people across India, in more than 5,500 villages and urban locations.

Survivors Say

Judith Jennings, of Meridianville, Ala., is a mother, grandmother, retired teacher and ovarian cancer survivor.

A lifetime commitment

Life Members of the MD Anderson Cancer Center Board of Visitors embody philanthropy, leadership and a community spirit. Through their dedication and devotion, this select group has furthered MD Anderson's mission and advanced the institution toward its goal to end cancer. Their belief in MD Anderson has motivated their personal generosity and inspired that of others. True ambassadors of Making Cancer History®, they've helped place MD Anderson at the forefront of cancer care, research, prevention and education. In 2015, the board welcomed two new Life Members: Lyda Hill of Dallas and James A. Baker, III, of Houston.